FindTrial
Sign In

Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19)

Optimization Protocal of Integrated Traditional Chinese and Western Medicine Treatment for Novel Coronavirus Pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030003
Enrollment
Unknown
Registered
2020-02-19
Start date
2020-02-19
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Group 1:Traditional Chinese Medicine prescription No. 1 and 2
Group 2:Gankeshuangqing capsule
Group 3:Shuanghuanglian oral liquid

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients with mild who are in compliance with the "Pneumonitis Diagnosis and Treatment Program for COVID-19(Trial Fifth Edition)" (released on 2020.2.4); (2) Aged more than 18 years old; (3) Informed consent of the patient.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
hospital stay;Discharge rate;Site-specific hospital metastasis rate or severe conversion rate;Body temperature normalization time;Clinical symptoms disappearance rate;—

Countries

China

Contacts

Public ContactTang Jianyuan

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

tangjianyuan163@163.com+86 13910768464

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026